CIDP Infusion Treatment
AmeriPharma Specialty Care provides expert infusion therapy for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), offering personalized care, insurance coordination, and clinical monitoring to support long-term symptom management.
When Are CIDP Infusions Recommended?
Infusion therapy is often used as a first-line treatment for CIDP because it helps regulate the immune system and reduce nerve inflammation. It may be recommended for patients who require ongoing immune modulation to prevent symptom relapse, preserve nerve function, and maintain muscle strength over time.
Patients who may benefit from CIDP infusion therapy include:
- Individuals with a confirmed CIDP diagnosis, typically established through clinical evaluation and electrodiagnostic testing
- Patients experiencing progressive or relapsing symptoms, such as worsening weakness, numbness, tingling, or loss of coordination
- Those with moderate to severe muscle weakness that interferes with daily activities like walking, climbing stairs, or lifting objects
- Patients who require maintenance therapy to prevent symptom relapse and maintain neurological function
- Individuals who have not responded adequately to corticosteroids alone, or who need an alternative long-term treatment option
FDA-Approved Infusion Therapies for CIDP
Intravenous Immunoglobulin (IVIG) Therapies
Intravenous immunoglobulin (IVIG) is one of the primary first-line treatments for CIDP. It works by delivering purified antibodies directly into the bloodstream, helping regulate immune system activity and reduce inflammation that damages the nerves. Several FDA-approved IVIG products are available for the treatment of CIDP. IVIG therapy typically begins with a loading dose to rapidly build up protective antibody levels in the body, followed by ongoing maintenance infusions. These maintenance infusions are typically administered every 3–4 weeks, although the exact dosing schedule is individualized based on each patient’s clinical response and treatment needs.
Corticosteroids
Corticosteroids, such as prednisone, are among the most established medications used to treat CIDP. These drugs help control the condition by suppressing the body’s immune response. By reducing immune system activity, corticosteroids decrease inflammation around the nerves and help prevent further damage to the protective myelin sheath that surrounds them.
Subcutaneous Immunoglobulin (SCIG) Options
Subcutaneous immunoglobulin (SCIG) therapy delivers purified antibodies under the skin rather than directly into the bloodstream. This allows for slower, steady absorption, helping maintain more consistent antibody levels over time. SCIG is used to treat conditions such as immunodeficiencies and autoimmune disorders like CIDP, and offers a flexible alternative to IVIG with the option for more frequent, lower-dose infusions that may be self-administered at home.
Vyvgart Hytrulo
Vyvgart Hytrulo was approved by the FDA in 2024 for the treatment of CIDP in adults. This therapy combines efgartigimod alfa, a neonatal Fc receptor (FcRn) blocker, with hyaluronidase, which helps enhance the medication’s absorption. By targeting FcRn, the treatment reduces levels of harmful antibodies that contribute to nerve damage in CIDP. Vyvgart Hytrulo represents a promising newer treatment option, particularly for patients who have not responded well to traditional therapies such as IVIG or plasmapheresis.
Get CIDP Infusion Care With AmeriPharma® Specialty Care
Proactive, Personalized CIDP Care
- Dedicated clinicians to oversee your care
- Ongoing monitoring and treatment adjustments as needed
- Close coordination with your neurologist and care team
Expert Clinical Team
- Clinical pharmacists specializing in infusion therapies
- Experienced infusion nurses trained in infusion protocols
- Committed patient care coordinators managing scheduling and serving as a consistent point of contact for questions and ongoing support
Comfortable Outpatient Setting & Flexible Scheduling
- Private, calm infusion suites—not a hospital environment
- Amenities to help you relax during treatment
- Infusions may also be administered in the comfort of your home
- Flexible appointment times, including evenings and weekends
Insurance Support & Financial Assistance
- Full insurance coordination, prior Full insurance verification and prior authorization handling
- Medicare and most major private insurance plans are accepted
- Financial assistance programs for qualifying patients
- Clear breakdown of copays before treatment begins
We accept Medicare and most major private insurance plans.
Call us to find out more about your coverage.
How Does CIDP Infusion Treatment Work?
-
Step 1: Insurance Verification & Prior Authorization
Your care begins with AmeriPharma’s team handling insurance verification and prior authorization paperwork. We coordinate with your prescribing neurologist to ensure a smooth approval process, typically completed within a few days.
-
Step 2: Scheduling Your Appointment
Once approved, we schedule your infusion at a time that works for you. Flexible scheduling options—including evenings and weekends where available—help minimize disruption to your daily life.
-
Step 3: Comfortable Infusion Experience
During your appointment, you’ll relax in a comfortable setting while a well-trained nurse takes care of your infusion and monitors you throughout treatment. If needed, a small IV catheter will be placed, or your existing port, PICC, or central line will be accessed. For subcutaneous therapy, medication will be administered under the skin using small needles. Infusions may take 30 minutes to several hours, depending on your medication. You can relax, read, watch TV, or use your devices during treatment.
-
Step 4: Ongoing Monitoring & Clinical Support
Our clinical staff monitors for any reactions and provides post-infusion support. Follow-up infusions are scheduled based on your treatment protocol, and our care team stays in communication with your neurologist to track your progress.
Testimonials
Service Area
AmeriPharma’s CIDP infusion services are available in multiple states throughout the US. We are fully licensed and able to extend our services in the areas marked in blue on the map.
Frequently Asked Questions about CIDP
How long does a CIDP infusion take?
The length of a CIDP infusion depends on your dose being administered and your individual treatment plan. IVIG infusions typically take between 2 to 4 hours per session, although the first infusion may take longer, so your care team can monitor how you respond. This initial treatment is often a loading dose, which may be administered over a longer period or across multiple consecutive days at the start of therapy. Your infusion schedule and duration will be determined by your physician based on your dosage, treatment goals, and how well you tolerate the infusion.
How do I prepare my home for home infusion?
Preparing for home infusion therapy is usually simple. Choose a clean, comfortable area in your home where you can sit or recline during the infusion. Have a small table or nearby surface available to organize your supplies, and ensure the area is free from distractions, including children and pets, during treatment. Many patients also like to have water, snacks, a blanket, or entertainment such as a book or television available during treatment. Your supplies will be delivered directly to your home, and your infusion nurse will administer the treatment and monitor you throughout the process to ensure it is safe and comfortable.
What happens if I have a reaction during the infusion?
Although most patients tolerate CIDP infusions well, mild infusion-related reactions can sometimes occur. These may include headache, nausea, rash, chills, flushing, or fatigue. During home infusion therapy, a trained nurse will monitor you throughout the treatment and can slow or temporarily stop the infusion if symptoms occur. Medications may also be given to help relieve symptoms. Severe reactions are rare, but your care team is trained to manage them and will contact your physician if needed.
Can I continue my other CIDP medications while receiving infusion therapy?
In many cases, patients continue taking other CIDP medications while receiving infusion therapy. Treatments such as corticosteroids or other immunomodulating medications may be used together, depending on your individual care plan. Your neurologist will determine the safest and most effective combination of therapies and may adjust medications as your symptoms improve.
Will I need CIDP infusions indefinitely?
The duration of infusion therapy varies from patient to patient. Some individuals require ongoing maintenance infusions to help control symptoms and prevent relapse, while others may be able to reduce the frequency of treatment over time if their condition stabilizes. Your neurologist will regularly evaluate your response to therapy and adjust your treatment plan based on your symptoms, strength, and overall disease activity.
Start Your CIDP Infusion Care Today
AmeriPharma® Specialty Care provides personalized CIDP infusion therapy with expert clinical support, insurance coordination, and a comfortable outpatient experience. Get started today with a trusted specialty pharmacy that makes managing CIDP easier.
Resources
-
A Guide to the Most Effective CIDP Disease Treatment Options
Chronic inflammatory demyelinating polyneuropathy (CIDP) is not just a complicated…
-
CIDP vs. ALS: What Is the Difference?
Chronic inflammatory demyelinating polyneuropathy (CIDP) and amyotrophic lateral sclerosis (ALS) are…
-
CIDP and Physical Therapy: How Supervised Exercises Can Help Improve Quality of Life
Chronic inflammatory demyelinating polyneuropathy (CIDP) reduces your ability to perform…
-
Can CIDP Be Reversed? A Closer Look at the Evidence
Though CIDP is treatable and some symptoms can be reversed,…